Summit Creek Advisors LLC increased its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 23.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 58,135 shares of the scientific and technical instruments company's stock after acquiring an additional 11,165 shares during the quarter. Transcat comprises about 2.1% of Summit Creek Advisors LLC's investment portfolio, making the stock its 22nd largest holding. Summit Creek Advisors LLC owned approximately 0.62% of Transcat worth $5,140,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Transcat in the 3rd quarter valued at about $221,000. GAMMA Investing LLC increased its holdings in shares of Transcat by 133.6% during the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company's stock worth $91,000 after purchasing an additional 589 shares during the period. Tidal Investments LLC bought a new position in shares of Transcat during the second quarter worth approximately $688,000. Integrated Wealth Concepts LLC bought a new position in shares of Transcat during the second quarter worth approximately $32,000. Finally, Squarepoint Ops LLC raised its position in shares of Transcat by 9.0% in the second quarter. Squarepoint Ops LLC now owns 8,794 shares of the scientific and technical instruments company's stock valued at $816,000 after buying an additional 728 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.
Insider Transactions at Transcat
In other news, CEO Jaime A. Irick acquired 2,275 shares of the stock in a transaction on Thursday, November 5th. The stock was acquired at an average cost of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the transaction, the chief executive officer directly owned 2,275 shares in the company, valued at approximately $230,366.50. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 1.80% of the stock is owned by company insiders.
Key Headlines Impacting Transcat
Here are the key news stories impacting Transcat this week:
- Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
- Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
- Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
- Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
- Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target
Transcat Price Performance
Shares of NASDAQ:TRNS opened at $101.51 on Friday. The firm has a 50 day moving average of $86.94 and a 200-day moving average of $82.43. The stock has a market capitalization of $954.70 million, a PE ratio of 211.48 and a beta of 0.61. The company has a current ratio of 2.57, a quick ratio of 2.11 and a debt-to-equity ratio of 0.38. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $110.47.
Transcat (NASDAQ:TRNS - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.19. The company had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. Transcat had a net margin of 1.26% and a return on equity of 6.14%. On average, equities research analysts predict that Transcat, Inc. will post 2.06 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the company. Northland Securities upgraded Transcat from a "market perform" rating to an "outperform" rating and set a $95.00 price target for the company in a research note on Wednesday, October 21st. CJS Securities initiated coverage on Transcat in a research note on Tuesday, October 27th. They set an "outperform" rating and a $115.00 price objective on the stock. Oppenheimer upgraded Transcat from a "market perform" rating to an "outperform" rating and set a $115.00 price objective on the stock in a research note on Wednesday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Transcat in a report on Tuesday, August 25th. Finally, Zacks Research upgraded Transcat from a "hold" rating to a "strong-buy" rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $108.33.
Check Out Our Latest Research Report on TRNS
Transcat Company Profile
(
Free Report)
Transcat, Inc NASDAQ: TRNS provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.
Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.